1
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-6 and Disease

Two Case Reports that Point to the Usefulness of Measuring Cytokine Levels in Clinical Settings

&
Pages 53-69 | Published online: 04 Dec 2011

References

  • Licinio J, Wong M-L. Interleukin 113 and fever. Nature Medicine 1996; 2:1314–1315.
  • Alcami A, Smith GL. A mechanism for the inhibition of fever by a virus. Frac. Natl. Aced. Sci. USA 119693:11029–11034.
  • Schotanus K, Holtkatnp GM, van Rooijen N, Tildres FJ, Berkenhosch F. Circulating tumor necrosis factor-alpha does not mediate endotoxin-induced hy-pothermia in rats. Am. J. Physiol. 1995;268:989–996.
  • Chai Z, Alheim K, Lundkvist J, Gatti S, Bartfai T. Subchronic glueocorti-coid pretreatment reversibly attenuates IL-I beta-induced fever in rats; IL-6 mRNA is elevated while IL-1 alpha and IL-1 beta mRNAs are suppressed, in the CNS. Cytokine 1996;8: 227–237.
  • Reuler 113. Hypothermia: Pathophysiology, clinical settings, and manage-ment. Ann. Intern. Med. I 978;89:519–527.
  • Kloos RT. Spontaneous periodic hypothermia. Medicine 1995;74: 268–280.
  • Okada M, Nishimura F, Yoshino H, et al. The J wave in accidental hypo-thermia. J. Electrocardiol. 1983;16:23–28.
  • Saper CB. The neurologic basis of fever. N. Engl. J. Med. 1994;330: 1880–1886.
  • Sjogren H. Zur Kenntnis der keratoconjuctivitis sicca. Acta Ophthalmo, (Copenh) 1933; I l\(Suppl 2): I -151.
  • Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Zhang HL. Detection of a human intracisiernal A-type retroviral particle antigenically related to HIV. Science 1990;23:1127–1129.
  • Brookes SM, Boyd M, Stevens R, Whitby D, Shattles WG, Venables PJW, Schultz T, Maini RN. A novel retroviral sequence in Sjogren's syndrome salivary gland biopsy co-cultures (abstract). Arthritis Rheum. 1992;35 (suppl 9):S64.
  • Talal N, Dauphin& MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detec-tion of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 1990;33:774–781.
  • Talal N, Garry RE, Schur PH, Alexander S, Dauphin& MJ, Livas IH, Bal-tester A, Takei M, Dang H. A conserved idiotype and antilx,dies to retroviral pro-teins in systemic lupus erythematosus. J. Clin. Invest. 1990;85:1866–1878.
  • MeilofJF, Arentsen H, Kruize AA, Nene RJ, Bijlsma JWJ, van der Poel CL, Smeenk RJT, Huisman JG. Sjogren's syndrome and retroviral infection (let-ter). Arthritis Rheutn. 1992;35:1403–1404.
  • Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y. Primary Sjogren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann. Rheum. Dis. 1992;51:769–776.
  • Shattles WG, Brookes SM, Venables PJW, Clark DA, Maini RN. Expres-sion of antigen reactive with a monoclonal antibody to HTLV-I p I 9 in salivary glands in Sjogren's syndrome. Clin. Exp. Immunol. 1992;89: 46–51.
  • Schot M, Greenspan D, Levy J, et al. Does HIV cause salivary gland dis-ease? AIDS 1989;3:819–822,
  • Vernant JC, Buisson G, Magdeleine J, de 'More J, Jouannelle A, Neisson-Vernant C, Montplaisir N. T-lymphocyte alveolitis, tropical spastic paraparesis, and Sjogren's syndrome (letter). Lancet 1988;1 :177.
  • Ulrisch RC, Jaffee ES. Sjogren's syndrome-like illness associated with the acquired immune deficiency syndrome related complex. Hum. Pathol. 1987;18: 1063–1068.
  • De Clerck LS, Couttenye MM, dc Broe ME, Stevens WJ. Acquired immu-nodeficiency syndrome inimicking Sjägren's syndrome and systemic lupus cry-thematosus. Arthritis Rheum. 1988;31:272–275.
  • Calabrese LH, Wilke WS, Perkins AL, Tubbs RR. Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the devel-opment of Sjögren's syndrome. Arthritis Rheum. 1989;32:1453–1457.
  • Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinoptithy resembling SjOgren's syndrome in HTLV-I tax transgenic mice. Nature 1989;34 I :72–74.
  • Garry RF. New evidence for involvement of retroviruses in Sjägren's syn-drome and other autoimmune diseases. Arthritis Rheum. I994;37(4):465–469.
  • Sumida T, Yonaha F, Maeda T, Kita Y, Iwamoto% Koike T, Yoshida S. Ex-pression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjogren's syndrome. Arthritis Rheum. 1994;37: 545–550.
  • Marietta X, Agbalika F, Daniel M-T, Bisson M, Lagrange P, Brouet J-C, Morinet F. Detection of human I lymphotropic virus type I tux gene in salivary gland epithelium from two patients with Sjogren's syndrome. Arthritis Rheum. 1993;36:1423–1428.
  • Blick M, Bresser J, Lepe-Zuniga IL, Goodacre A, Euethke D, Holder WR, Duvic M. Identification of HIV hybridizing sequences in the peripheral blood of a patient with systemic lupus erythcmatosus. J. Am. Acad. Dermatol. 1990;23:641–645.
  • Araga S, Takai 11, Takahashi K. Interleukin-6 levels in the cerebrospinal fluid of patients with multiple sclerosis. Jap. J. Psych. Neural. 1991;45: 879–883.
  • Campolillo A, Marini V, Mirakian R— Buscema M, Schulz T, Pujol-Borrell R, Bottazzo OF. Retrovirus-likc sequences in Graves disease: implications for hu-man autoimmunity. Lancet 1989;1:1096–1100.
  • Lagaye S, Vexiau P, Morozov V, Guénebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Gerard C, Peries 3, Emanoil-Ravicr R. Human spumareirovirus-re-lated sequences in the DNA of leukocytes from patients with Graves disease. Proc. Nall. Acad. Sci. USA 1992;89:10070–10074.
  • Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to in-tegration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 1993; 178:461–468.
  • Ziemiecki A, Kromer G, Mueller RG, Hala K, Wick G. Ey22, a new en-dogenous avian leukosis virus locus found in chickens with spontaneous autoirn-mune thyroiditis. Arch. Virol. 1988;100: 267–271.
  • Perl A, Gorevic PD, Condemi JJ, Papsidero L, Poiesz BJ, Abraham ON. Antibodies to retroviral proteins and reverse transcriptase activity in patients with essential cryoglobulinemia. Arthritis Rheum. 1991; 34:1313–1318.
  • Dang ft Dauphinee MJ, Talal N, Garry RF, Seibold JR, Medsger TA Jr, Alexander S. Serum antibody to retroviral gag proteins in systemic sclerosis. Ar-thritis Rheum. 1991;34:1336–1337.
  • Vogel J, Hinrichs Si-I, Napolitano LA, Ngo L, Jay G. Liver cancer in trans-genic mice carrying the human immunodeficiency virus rat gene. Cancer Res. 1991;51:6686–6690.
  • Kaplan JG, Rosenberg R, Reinitz E, Buchbinder S, Schaumburg 1-11-1. In-vited review: Peripheral neuropathy in Sjogren's syndrome. Muscle & Nerve 1990;13: 570–579.
  • Frei K, Leist TP, Meager A, Gallo P, Leppert S, Zinkernagel RM, Fontana A. Production of B cell stimulatory factor 2 and interferon-y in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model in-fection and in patients. J. Exp. Med. 1988;168: 449–453.
  • Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A. Tumor ne-crosis factor alpha in cerebrospinal fluid during bacterial but not viral meningitis. J. Exp. Med. 1988;167:1743–1748.
  • Mutsafa MM, Lebel MH, Ramilo O, Olsen KD, Resich JS, Beutler 13, McCracken GH. Con-elation of interleukin- 43 and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 1989; 115:208–213.
  • PereIla O, Rescigno C, Guamaccia D, Salvi A, Pempinello R, Garofalo G, Faella F. Cerebrospinal fluid interleukin-6 and IgE in bacterial and viral meningi-tis. Acta Neurol. 1992;14: 6–9.
  • Chavanet P, Bonnotte B, Guiguet M, Zeller V, Solary E, Maurice L, Casas-novas O, Caillot D, Wadner A, Kisterman JR High concentrations of intrathecal interleukin-h in human bacterial and nonbacterial meningitis. J. Mf. Dis. 1992; 166:428–431.
  • Houssiau FA, Bukasa K, Sindic CJM, van Damme J, van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of central nervous system. Clin. Exp. Ininut-no. 1988;71: 320–323.
  • Laurenzi M, Siden A, Persson MAA, Norkrans G, Hagberg L, Chiodi F. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory disease of the nervous system. Cl/n. Minium. intintinopathoi, 1990;57:233–241.
  • Matsuzono Y, Narita M, Akutsu Y, Togashi T. Interleukin-6 in cerebrospi-nal fluid of patients with central nervous system infections. Acta Paediatr. 1995; 84:879–883.
  • Rautonen J, Rautonen N. Tat and Kawasaki disease. Mumma Today 1992; 13:190.
  • Rautonen J, Rautonen N, Martin NL, Wara DW. HIV type 1 tat protein in-duces immunoglobulin and interleukin-6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res. Hum. Retrov. 1994; 10(7):78 1-785.
  • Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A. Human im-munodeficiency virus type I (HIV- I) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroinununol. 1989;23:109–116.
  • Ohbo K, Sugamura K, Sekizawa T, Kogure K. Interleukin-6 in cerebrospi-nal fluid of I ITLV-l-associated myelopathy. Neurology 1991 ;41:594–595.
  • Sabatier J-M, Vives E, Mabrouk K, Benjouod A, Rochat H, Duval A, Hue B, Bahraoui E. Evidence for neurotoxic activity of tat from human immunodefi-ciency virus type I. J. Km. 1991;65:961–967.
  • Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani AD, Domi-ni S, Ricciardi-Castagnoli P. Monokine production by microglial cell clones, Eur J. Immunol. 1989;19:1443–1448.
  • Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl, Acad. Sci. USA 1989;86:6348–6352.
  • Sharif SR, Hariri RJ, Chang VA, Bane PS, Wang RS, Ghajar JBG. Human astrocyte production of tumor necrosis factor-a, interlcukin-1 p and interleukin-6 following exposure to lipopolysaccharide endotoxin. Nemo. Res. 1993;15:109–112.
  • Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986; 29:577–585.
  • Fox RI, Carstens SA, Fong S, Robinson CA, Howell F, Vaughan J1-1. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in SjOgren's syndrome. Arthritis Rheum. 1982;25:419–426.
  • Targoff IN, keichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J. Immutiol. 1987;138:2874–2882.
  • Williams DG, Stocks MR, Charles PJ, Maini RN. Antibodies to La, Jo-1, nRNP and Sua detected by multitrack immunoblotting using a novel filter holder: a comparative study with counted mmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjogren's syn-drome. J. Immunol. Methods I 986;91:65–73.
  • Alexander E, McFarland H. Sjogren's syndrome and multiple sclerosis. Ann. Neural. 1991;29:455–456.
  • Escudero D, Olive A, LaTorre P. Pujol T, Coll J. Prevalence of Sjögren's syndrome in a neurology patient population. Ant. J. Med. 1992;92:34.
  • Hietaharju A, Korperla M, Honen J, Frey H. Nervous system disease, im-munological features, and HLA phenotype in Sjogren's syndrome. Ann. Rheum. Dis. 1992;51:506–509.
  • Arnett FC, Goldstein R, Duvic M, Reveille JD. Major histocompatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and poly-myositis. Ant. J. Med. 1988;85:38–41.
  • Morimoto C, Reinherz EL, Nadler LM, Distaso JA, Steinberg AD, Schloss-man SF. Comparison of T- and B-cell markers in patients with SjOgren's syn- drome and systemic lupus erythematosus.Immunol. Immunopathol. 1982;22:270–278.
  • Bakhshi A, Miyasaka N, Kavathas P, Daniels TE; Strand CV, Herzenberg LA, Talal N. Lymphocyte subsets in Sjögren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence activated cell sorter. J. ain. Lab. Immunol. 1983;10:63–69.
  • Youinou P, Pennec YL, Blaschek MA, Gentic A, Jouquan J, Lamour A, Angelidis P. Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome. Rheirmatol.988;8:125–130.
  • Sawada S, Sugai S. lijirna S, Takei M, Paredes E, Hayania T, Nishinarita S, Hosokawa Y, Hone T, Obara T. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome. Am. J. Med. 1992;92: 134–140.
  • Sugai S. Lymphoproliferative disorders in Japanese patients with Sjogren's syndrome. In: Talal N, Moutsopoulos HM, Kassen ES, Eds. Sjögren's syndrome, clinical immunological aspects. Berlin: Springer-Verlag, pp. 144–161.
  • Aloisi F, Cave A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C. Production of hemolymphopoietic cytokines (1L-6, 1L-8, colony-stimulating factors) by normal human astrocytes in response to 1L-10 and tumor necrosis factor-i. .1. Immunol. 1992;149:2358–2366.
  • Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokinc production in cerebrospinal fluid after subarachnoid haemorrhage. Neural. Res. 1995;17:106–108.
  • Tarkowski E, Rosengreen L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S. Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26: 1393–1398.
  • Rusconi F, Parizzi F, Garlaschi L, Assael BM, Sironi M, Ghezzi P, et al. Interleukin-6 activity in infants and children with bacterial meningitis. The col- laborative study on meningitis. Pediatr Infect. Dis.1991;10:117–121.
  • Schinder R, Mancilla .1, Endres S, Ghorbani G, Clark S, Dinarcllo CA, Cor-relations and interactions in the production of interleukin-6 (1L-6), IL-1 and tumor necrosis factor (TNIF) in human blood mononuclear cells: IL-6 suppresses IL-1 and INF. Blood 1990;75:40–47.
  • Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharidc-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Inununol. 1989;143: 3517–3523.
  • Alexander E. Central nervous system disease in Sjögren's syndrome. New insights into imtnunopathogenesis. Rheum. Dis. Clinics North Arne,: 1992;18: 637–672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.